Cannabis-TechnologiesCannabix Technologies, Inc is a unique company among the marijuana businesses that aim to fill the various needs of the industry. While there are research firms, cultivators, dispensaries, and marketers, Cannabix Technologies offers technology and a unique solution: a law enforcement tool called the Marijuana Breathalyzer.

The company started a couple of years before marijuana legitimization made the front pages in North American news. In 2011, the company was founded as West Point Resources, Inc. it started developing the cannabis breathalyzer tool under the brand name Cannabix. Then, in August 2014, at the height of the “green rush”, it changed its company name to Cannabix Technologies, Inc.

Currently, Cannabix Technologies is listed in the Canadian Securities Exchange as BLO, as well as in the US OTC markets as BLOZF. The company is valued at USD 7.4 M.

The Cannabix Marijuana Breathalyzer is its prime product. It is a drug-impairment recognition device that is similar to the alcohol breathalyzer currently used by authorities. Both tools test and analyze breath samples, but instead of alcohol levels, the Marijuana Breathalyzer detects tetrahydrocannabinol (THC), a psychoactive compound of marijuana.

Cannabix Technologies now markets this device as a tool to stop marijuana-intoxicated drivers. In addition, it can be used to inhibit THC-intoxicated employees where such intoxication could be considered a workplace hazard.

According to the company, the technology used in the Cannabix Marijuana Breathalyzer was sparked by a Swedish study on the same subject. It was then picked up by Cannabix President Kal Malhi, who formerly served in the Royal Canadian Mounted Police.

Aside from Malhi, top executives at Cannabix Technologies include CEO Rav Mlait, Chief Engineer Dr. Raj Attariwala, Senior Advisor Bruce Goldberger, and CFO Bryan Loree.


Yahoo! Finance: BLOZF News

Latest Financial News for BLOZF

7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk

The allure of investing in marijuana penny stocks can be very strong. Every investor has dreams of investing a couple thousand dollars in a penny stock, watching it go to $100 per share, and making millions of dollars. I know that I sure do.Even more tempting are penny stocks of companies that are in the marijuana industry. In this rapidly boom industry, it seems reasonable to assume that there are some hidden gems out there.But you need to be careful when investing in low prices stocks because most of these companies will not survive. After all, there is a reason why they trade at such low prices.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Defense Stocks to Buy to Fortify Your Portfolio The following seven marijuana penny stocks are worth considering for different reasons. These are not recommendations. I just want to give you some insights to help you make a decisions. Emerald Health Therapeutics Inc. (EMHTF) Click to EnlargeEmerald Health Therapeutics (OTCMKTS:EMHTF) is a pharmaceutical company that produces and sells cannabis products.I think that there will soon be a price war in the cannabis industry. That is because investors are starting to realize that the costs savings of growing cannabis outside outweigh any benefits that growing indoors or in greenhouses.The large growers like Tilray (NASDAQ:TLRY), Cronos (NASDAQ:CRON), Aphria (NYSE:APHA) and Aurora (NYSE:ACB) primarily grow indoors or in greenhouses. They may have difficult time competing with the outdoors growers that can offer their customers much lower prices.Emerald Health grows in greenhouses but they are moving into outdoor growing. The company just received it cultivation license from Health Canada for a 12-acre outside grow area. This early move into outside growing could be a very bullish dynamic.Technically, this could be a logical place to buy EMHTF. It is a level that was support in December. It is also very oversold. 48North Cannabis Corp (NRTH) Click to Enlarge48North Cannabis Corp (TSE:NRTH) grows and sells medical marijuana.NRTH is also moving towards outdoor growing. The company announced last week that it successfully completed the planting of its first outdoor cannabis crop. This was at their 100-acre farm in Bryant County, Ont.This farm has 3.7 million square feet of growing space and the ability to yield over 100,000 pounds per harvest. That's a lot of weed. And its organic.I think that in addition to the cost savings, outdoor growing may have two other advantages as well. Some marijuana aficionados say that the best marijuana is grown in natural sunlight, so there may be an advantage in quality. * 7 Stocks to Buy This Summer Earnings Season The second advantage could be that growing in natural sunlight is socially conscious. The indoor growers need a tremendous amount of electricity for their operations and that results in pollution. Many customers of this industry are very concerned about climate change so this may affect their buying decisions. Cannabix Technologies Inc. (BLOZF) Click to EnlargeCannabix Technologies Inc. (OTCMKTS:BLOZF) develops and manufactures marijuana breathalyzers for the police. The stock symbol is pretty cool. BLOZ which is pronounced as blows. The F is added because it is a foreign company.I like idea behind Cannabix but I am not so sure that its future prospects are good. Unfortunately for BLOZF shareholders, the company has not turned a profit in the past 5 years. The stock just broke support at the 80 cents level. This level will now probably become a resistance level.Support becomes resistance because people who bought the stock at 80 cents are now losing money. They tell themselves that if it rallies back to 80, they will sell it. This sell interest creates the resistance level. Medipharm Labs Corp. (MEDIF) Click to EnlargeMedipharm Labs Corp. (OTCMKTS:MEDIF) is a medical cannabis company that focuses on downstream extraction and purification technologies.This company caught my attention due to the increased trading volume. This shows that maybe some of the bigger Walls Street funds or investors are getting involved.Medipharm just announced that it is moving from the Toronto Venture Exchange to the Toronto Stock Exchange. When a company moves its stock what is considered a higher tier exchange, such as in this case, it means that it will have more transparency and will make more disclosures. * 10 High-Flying, Overvalued Stocks in Danger of Crashing This is typically considered a bullish development for a company. Being on a higher tiered exchange gives it more credibility and makes it more appealing to investors. Neptune Wellness Solutions Inc. (NEPT) Click to EnlargeNeptune Wellness Solutions Inc. (NASDAQ:NEPT) engages in the extraction, purification, and formulation of cannabis products. This company caught my attention because it has been trending higher all year. Then yesterday, some positive news hit the tape.NEPT raised $41 million in a private placement. This means they issued new shares to private institutional investors in exchange for the cash. Shareholders must believe this is great news because the stock was up over 10% yesterday.Two Wall Street firms follow NEPT and they each have buy ratings on it. The average target price is $8.50. Valens Groworks Corp. (VGWCF) Click to EnlargeValens Groworks Corp. (OTCMKTS:VGWCF) is a biotechnology company that provides products which are developed from proprietary extraction techniques.This company has been trending higher since the beginning of the year. On July 15th, it released its second-quarter results. These showed that the company has made some significant improvements.Revenue increased to $8.8 million CAD. This was a 296% increase from the first quarter. Gross profit was $5.1 million CAD, which was 58% of revenue as compared to 38% for the first quarter. * 7 Defense Stocks to Buy to Fortify Your Portfolio Wall Street is very bullish on this stock. 4 firms follow it and they all have it rated as a buy. The average price target is $8.20, which is about 150% higher than current levels. PAO Group Inc. (PAOG) Click to EnlargePAO Group Inc. (OTCMKTS:PAOG) is a holding company which is dedicated to alternative patient care treatments.I have included this company to illustrate how some advertising in the financial media can be extremely mislead if not downright fraudulent.I am sure you have seen adds touting the recent alleged great performance of this or that recent recommendation. Ads that say thing like "this stock doubled" or "this stock is up 1,000%" are everywhere. Even though some of these headlines may technically be correct they can also be very misleading.For example, every stock has a bid and an offer. The bid is the highest price someone will pay for it and the offer is the lowest price someone will sell it for.Suppose a penny stock has a bid of 1 cent and an offer of 2 cents. If is someone sells it the last trade will be 1 cent. Then suppose some buys it. Now the last trade is 2 cents. The price has doubled, but the stock hasn't moved!Take a look at the PAOG price scale on the chart. This stock trades not in pennies but in ten thousandths of a penny. It could rise 1000% from 24 ten thousands to 240 ten thousandths. But there is no way you can make money. The trading costs would make it impossible to profit.So be careful when you see advertisements promoting supposed great returns. These returns may just be trading anomalies to are impossible to profit from.As of this writing the author held no positions in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Defense Stocks to Buy to Fortify Your Portfolio * 10 High-Flying, Overvalued Stocks in Danger of Crashing * 8 Stocks to Buy That Are Growing Faster Than Amazon The post 7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk appeared first on InvestorPlace.

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and THC Breath Capture

The Cannabix Marijuana Breathalyzer is being developed to provide law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company” or “Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have made significant advancements with analyte in breath capture and FAIMS cell development.  Cannabix scientists have been optimizing the breath / sample capture procedures and technology to maximize ∆9-tetrahydrocannabinol (“THC”) analyte capture from human breath.

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and Renews Research with Yost Group

The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company engineers have made a significant breakthrough with the ionization module which is a vital component of the breathalyzer device, where breath samples are ionized prior to entrance into the FAIMS cell. The Company also reports that it has been steadily progressing with human breath testing at its Vancouver, BC, based lab with its FAIMS (field asymmetric waveform ion mobility spectrometry) ∆9-tetrahydrocannabinol (“THC”) detection device and breath collection unit (“BCU”).

Cannabix Technologies Adds Dr. Randall Purves as Scientific Advisor

The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 13, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company”) is pleased to announce that Dr. Randy Purves has been appointed as a Scientific Advisor to Cannabix Technologies Inc. Dr. Purves is one of the world’s foremost experts in the development of FAIMS (high-field asymmetric waveform ion mobility spectrometry) instrumentation and applications. Dr. Purves is a pioneer in developing FAIMS technology and in 2001 he co-founded Ionalytics, an instrument company specializing in FAIMS devices for use with mass spectrometry.

Approved Roadside Saliva Test Faces Court Challenge in Canada -- CFN Media

Seattle, Washington--(Newsfile Corp. - April 30, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article discussing Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) and its development of the Cannabix Marijuana Breathalyzer, seeking to provide consistent, convenient, and accurate THC detection for both law enforcement and workplace applications.In August of 2018 the Canadian federal government approved ...